title: Allelic association study between phospholipase A2 genes and bipolar affective disorder.
abstract: OBJECTIVE
  In vivo studies demonstrating that lithium is a powerful phospholipase A2 (PLA2) inhibitor suggest that PLA2 activation, and subsequent cell signaling overactivation by increased fatty acid release may be the primary abnormality in bipolar affective disorder (BPAD), thus making PLA2 genes attractive candidates for the susceptibility to BPAD. The present study investigates polymorphisms in cytosolic phospholipase A2 (cPLA2), calcium-independent phospholipase A2 (iPLA2), and secretory phospholipase (sPLA2) genes in a Brazilian sample.
  
  
  METHODS
  A cross-sectional study was performed with 181 unrelated DSM-IIIR BPAD subjects and 312 controls. A polymerase chain reaction-restriction fragment length polymorphism assay for BanI cPLA2 and AvrII iPLA2 polymorphisms was performed, and an ATT repeat in sPLA2 was assessed using a semiautomated genetic analyzer (ALFexpress).
  
  
  RESULTS
  There was no significant difference observed in the allelic and genotypic distribution between the BPAD and control groups for cPLA2 (genotype: chi2 = 0.8, 2df, p = 0.6; allele chi2 = 0, 1df, p = 0.9), iPLA2 (genotype: chi2 = 1.7, 2df, p = 0.4; allele: chi2 = 0.3, 1df, p = 0.6), and sPLA2 (allele: chi2 = 3.6, 6df, p = 0.8).
  
  
  CONCLUSIONS
  Our results failed to demonstrate that the studied PLA2 polymorphisms were associated with an increased risk for BPAD in our sample.
authors.affiliation: Laboratory of Neuroscience, Institute of Psychiatry, University of Sao Paulo Medical School, Sao Paulo, SP, Brazil.
authors.forename: Ivanor
authors.initials: I
authors.lastname: Meira-Lima
authors.forename: Daniela
authors.initials: D
authors.lastname: Jardim
authors.forename: Ricardo
authors.initials: R
authors.lastname: Junqueira
authors.forename: Elisa
authors.initials: E
authors.lastname: Ikenaga
authors.forename: Homero
authors.initials: H
authors.lastname: Vallada
mesh_terms: D000328:Adult; D001714:Bipolar Disorder / Q000235:genetics*; D003430:Cross-Sectional Studies; D017931:DNA Primers / Q000235:genetics; D005260:Female; D015870:Gene Expression / Q000235:genetics; D005787:Gene Frequency / Q000235:genetics*; D005838:Genotype; D054501:Group II Phospholipases A2; D054513:Group IV Phospholipases A2; D054522:Group VI Phospholipases A2; D006801:Humans; D008297:Male; D010741:Phospholipases A / Q000235:genetics*; D054467:Phospholipases A2; D011110:Polymorphism, Genetic / Q000235:genetics
chemical_list: D017931:DNA Primers; D010741:Phospholipases A; D054501:Group II Phospholipases A2; D054513:Group IV Phospholipases A2; D054522:Group VI Phospholipases A2; C516475:PLA2G6 protein, human; D054467:Phospholipases A2